Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01667536
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

99mtc mip 1404 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1